Sano Genetics | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision...
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.
Website
Headquarters
Cambridge, England
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Genetics, Big Data, Research
🛍️ Sano Genetics Product and Pricing News →
👔 Sano Genetics CEO, Management and Leadership Team →
⚔️ Sano Genetics Alternatives and Competitors →
💼 Sano Genetics Hiring and Layoffs →
🤖 Sano Genetics Developer, Integration and Automation News →
📈 Sano Genetics Financials, Fundraising and Valuation News →
🛍️ Sano Genetics Product and Pricing News
- Charlotte Guzzo, Co-founder and COO of Sano Genetics, is mentioned as a speaker at the Tech.eu Summit London 2025.
- Sano Genetics is hosting a casual get-together at the American Society of Human Genetics event in Denver to celebrate over 150 episodes of The Genetics Podcast.
- Sano Genetics has been named in Bloomberg UK's Startups to Watch 2024 and announced a new partnership to enhance specialist eye care and research in the USA.
- Sano Genetics has been named one of Bloomberg's Startups to Watch 2024, highlighting their innovation and diversity.
- Sano Genetics is hosting the first-ever Genetics Podcast Meetup on November 7th in Denver.
- Sano Genetics won silver in the Global Good Awards for their Genetics of Long Covid study and analysis with PrecisionLife, identifying 42 genes for potential drug discovery.
- Sano Genetics released a whitepaper on global market expansion and the future of precision medicine.
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, co-authored a new paper on DEI in digital mental health interventions with Woebot Health, published in the Journal of Medical Internet Research.
👔 Sano Genetics CEO, Management and Leadership Team
-
Vice President of Neuroscience
[email protected] -
Co-Founder and CEO[email protected]
-
CTO and Cofounder[email protected]
-
Founder and COO[email protected]
⚔️ Sano Genetics Alternatives and Competitors
- Akkure |
- Invitae |
- PreventionGenetics |
- Phase Genomics |
- Arima Genomics |
- 10x Genomics |
- Helix |
- Geneticure |
- Eugene |
- MedySapiens |
- Molecular You |
- SITraN |
- Cellartis |
- Fios Genomics |
- Glasgow Precision Oncology Laboratory |
- Renovacor |
- Eikon Therapeutics |
- Interius BioTherapeutics |
- Dermavant Sciences |
- Metrum Research Group |
- Clovis Oncology
💼 Sano Genetics Hiring and Layoffs
- Sandra Bläser has left Sano Genetics, where she served as VP Customer Success & Delivery, Patient Recruitment & Engagement in Ireland, to join Causaly as Principal - Strategic Engagement EMEA.
- Benjamin Jackson has joined Sano Genetics as VP of Commercial in the United States, previously serving as Executive Vice President, Commercial at BC Platforms.
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, emphasized the importance of UK participants benefiting from promising drug research.
- Francesca Leivers has left Sano Genetics as an Executive Assistant in the United Kingdom to join C the Signs as an Executive Assistant.
- As of October 28, 2024, Sano Genetics pays its employees an average salary ranging from £40,000 for a Content Manager to £151,004 for an Executive, with an overall compensation and benefits rating of 4.6 out of 5 stars.
- Amy Cousins, Senior Content Manager at Sano Genetics, is praised for her exceptional work and consultancy skills.
🤖 Sano Genetics Developer, Integration and Automation News
- Sano Genetics is partnering with Glanzmann's Research Foundation and Hemab Therapeutics to conduct a survey on the daily life impacts of Glanzmann Thrombasthenia.
- Sano Genetics partners with Neuron23 to streamline patient referrals and provide genetic testing and counseling for the NEULARK clinical trial in early Parkinson's disease.
- Sano Genetics partners with Lifebit and Lupus Research to establish DREAM, a secure data platform for lupus research and treatments.
- Sano Genetics is collaborating with the Lupus Research Alliance to enhance patient engagement in the DREAM platform by enabling lupus patients to participate in research and access their data.
- Sano Genetics is supporting a research program with Prevail Therapeutics to provide free at-home genetic testing and counseling for frontotemporal dementia (FTD).
- Sano Genetics has launched a new partnership with 20/20 Onsite and Clinical Enrollment to improve participant selection for inherited retinal disease trials, announced during the American Academy of Ophthalmology event in Chicago.
📈 Sano Genetics Financials, Fundraising and Valuation News
People also viewed
- Numerade |
- VSPARTICLE |
- Unitary |
- Starship Technologies |
- Robin AI |
- PipeDreams |
- Womp Labs |
- Monumental
